Prognostic significance of p53 and KAI-1 expression in patients with laryngeal squamous cell carcinoma

Analytical and Quantitative Cytology and Histology

Volumn 32, Issue 5, 2010, Pages 247-253

  Re, Massimo ^a   Magliulo, Giuseppe ^b   Salvolini, Eleonora ^a   Orciani, Monia ^a   Gioacchini, Federico Maria ^a   Goteri, Gaia ^a   Rubini, Corrado ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Immunohistochemistry; KAI 1; Larynx; P53; Prognostic factors; Squamous cell carcinoma

Indexed keywords

FORMALDEHYDE; PARAFFIN; PHOSPHOPROTEIN; PROTEIN KAI 1; PROTEIN P53; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER SURGERY; CORRELATION ANALYSIS; DOWN REGULATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARYNX CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; STAINING; UPREGULATION; LARYNX TUMOR; RETROSPECTIVE STUDY;

CARCINOMA, SQUAMOUS CELL; HUMANS; IMMUNOHISTOCHEMISTRY; LARYNGEAL NEOPLASMS; RETROSPECTIVE STUDIES; TUMOR SUPPRESSOR PROTEIN P53;

EID: 78349233849     PISSN: 08846812     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Lehnerdt GF, Franz P, Winterhoff S, Bankfalvi A, Grehl S, Lang S, Schmid KW, Siffert W, Jahnke K, Frey UH: The GNAS1 T393C polymorphism predicts survival in patients with advanced squamous cell carcinoma of the larynx. Laryngoscope 2008;118:2172-2176
2. Carracedo DG, Astudillo A, Rodrigo JP, Suarez C, Gonzalez MV: Skp2, p27kip1 and EGFR assessment in head and neck squamous cell carcinoma: Prognostic implications. Oncol Rep 2008;20:589-595
3. Cabelguenne A, Blons H, de Waziers I, Carnot F, Houllier AM, Soussi T, Brasnu D, Beaune P, Laccourreye O, Laurent-Puig P: p53 alterations predict tumor response to neoadjuvant chemotherapy in head and neck squamous cell carcinoma: A prospective series. J Clin Oncol 2000;18:1465-1473
4. Kokoska MS, Piccirillo JF, El-Mofty SK, Enami B, Haughey BH, Sholnick SB: Prognostic significance of clinical factors and p53 expression in patients with glottic carcinoma treated with radiation therapy. Cancer 1996;78:1693-1700
5. Nadal A, Campo E, Pinto J, Mallofré C, Palacín A, Arias C, Traserra J, Cardesa A: p53 expression in normal, dysplastic, and neoplastic laryngeal epithelium: Absence of correlation with prognostic factors. J Pathol 1995;175:181-188
6. Dursun G, Sak SD, Akyol G, Dursun A, Erekul S, Demireller A, Akiner M: Overexpression of p53 protein in laryngeal carcinoma: Clinicopathological implications. Ear Nose Throat J 1995;74:645-648
7. Friedman M, Lim JW, Manders E, Schaffner AD, Kirshenbaum GL, Tanyeri HM, Caldarelli DD, Coon JS: Prognostic significance of bcl-2 and p53 expression in advanced laryngeal squamous cell carcinoma. Head Neck 2001;23:280-285
8. Gluckman JL, Stambrook PJ, Pavelic ZP: Prognostic significance of p53 protein accumulation in early stage T1 oral cavity cancer. Eur J Cancer B Oral Oncol 1994;30B:281
9. Klatka J: Prognostic value of the expression of p53 and bcl-2 in patients with laryngeal carcinoma. Eur Arch Otorhinolaryngol 2001;258:537-541
10. Nathan CO, Sanders K, Abreo FW, Nassar R, Glass J: Correlation of p53 and the proto-oncogene EIF4E in larynx cancers: Prognostic implications. Cancer Res 2000;60:3599-3604
11. Pruneri G, Pignataro L, Carboni N, Ronchetti D, Cesana BM, Ottaviani A, Neri A, Buffa R: Clinical relevance of p53 and bcl-2 protein over-expression in laryngeal squamous cell carcinoma. Int J Cancer 1998;79:263-268 (Pubitemid 28262211)
12. Salam MA, Croker J, Morris A: Over-expression of tumor suppressor gene p53 in laryngeal squamous cell carcinomas and its prognostic factor. Clin Otolaryngol 1995;20:49-52
13. Sittel C, Eckel H, Damm M: Ki67(MIB1), p53, and Lewis-X (LeuM1) as prognostic factors of the recurrence in T1 and T2 laryngeal carcinoma. Laryngoscope 2000;110:1012-1017
14. Dolcetti R, Doglioni C, Maestro R, Gasparotto D, Barzan L, Pastore A, Romanelli M, Boiocchi M: p53 over-expression is an early event in the development of human squamous-cell carcinoma of the larynx: Genetics and prognostic implications. Int J Cancer 1992;52:178-182
15. Jin YT, Kayser S, Kemp BL, Ordonez NG, Tucker SL, Clayman GL, Goepfert H, Luna MA, Batsakis JG, El-Naggar AK: The prognostic significance of the biomarkers p21, p53 and bcl-2 in laryngeal squamous cell carcinoma. Cancer 1998;82:2159-2165
16. Jäkel MC, Sellmann L, Dorudian MA, Youssef S, Füzesi L: Prognostic significance of p53/bcl-2 coexpression in patients with laryngeal squamous cell carcinoma. Laryngoscope 2000;110:1339-1345
17. Narayana A, Vaughan AT, Kathuria S, Fisher SG, Walter SA, Reddy SP: p53 overexpression is associated with bulky tumor and poor local control in T1 glottic cancer. Int J Radiat Oncol Biol Phys 2000;46:21-26
18. Nogueira CP, Dolan RW, Gooeye J, Byahatti S, Vaughan CW, Fuleihan NS, Grillone G, Baker E, Domanowski G: Inactivation of p53 and amplification of cyclin D1 correlate with clinical outcome in head and neck cancer. Laryngoscope 1998;108:345-350
19. Hirvikoski P, Kumpulainen E, Virtaniemi J, Johansson R, Haapasalo H, Marin S, Halonen P, Helin H, Raitiola H, Pukander J, Kellokumpu-Lehtinen P, Kosma VM: p53 expression and cell proliferation as prognostic factors in laryngeal squamous cell carcinoma. J Clin Oncol 1997;15:3111-3120
20. Xu JH, Guo XZ, Ren LH, Shao LC, Liu MP: KAI-1 is a potential target for anti-metastasis in pancreatic cancer cells. World J Gastroenterol 2008;14:1126-1132
21. Friess H, Guo XZ, Berberat P, Graber HU, Zimmermann A, Korc M, Buchler MW: Reduced KAI-1 expression in pancreatic cancer is associated with lymph node and distant metastases. Int J Cancer Predict Oncol 1998;79:349-355
22. Yu Y, Yang JL, Markovic B, Jackson P, Yardley G, Barret J, Russel PJ: Loss of KAI-1 messenger RNA expression in both high-grade and invasive human bladder cancer. Clin Cancer Res 1997;3:1045-1049
23. Yang X, Welch DR, Phillips KK, Weissman BE, Wei LL: KAI-1, a putative marker for metastatic potential in human breast cancer. Cancer Lett 1997;119:149-155
24. Adachi M, Taki T, Ieki Y, Huang CL, Higashiyama M, Miyake M: Correlation of KAI-1/CD82 gene expression with good prognosis in patients with non-small cell lung cancer. Cancer Res 1996;56:1751-1755
25. Lombardi DP, Geradts J, Foley JF, Chiao C, Lamb PW, Barrett JC: Loss of KAI-1 expression in the progression of colorectal cancer. Cancer Res 1999;59:5724-5731
26. Miyazaki T, Kato H, Shitara Y, Yoshikawa M, Tajima K, Masuda N, Shouji H, Tsukada K, Nakajima T, Kuwano H: Mutation and expression of the metastasis suppressor gene KAI-1 in esophageal squamous cell carcinoma. Cancer 2000;89:955-962
27. Uzawa K, Ono K, Suzuki H, Tanaka C, Yakushiji T, Yamamoto N, Yokoe H, Tanzawa H: High prevalence of decreased expression of KAI-1 metastasis suppressor of human oral carcinogenesis. Clin Cancer Res 2002;8:828-835
28. Dong JT, Rinkler-Schaeffer CW, Ichikawa T, Barrett JC, Isaacs JT: Prostate cancer-biology of metastasis and its clinical implications. World J Urol 1996;14:182-189
29. Jackson P, Marreiros A, Russel PJ: KAI-1 tetraspanin and metastasis suppressor. Int J Biochem Cell Biol 2005;37:530-534
30. Bandyopadhyay S, Zahn R, Chaudhuri A, Watabe M, Pai SK, Hirota S, Hosobe S, Tsukada T, Miura K, Takano Y, Saito K, Pauza ME, Hayashi S, Wang Y, Mohinta S, Mashimo T, Iiizumi M, Furuta E, Watabe K: Interaction of KAI-1 on tumor cells with DARC on vascular endothelium leads to metastasis suppression. Nat Med 2006;12:933-938
31. Chomchai JS, Du W, Sarkar FH, Li YW, Jacobs JR, Ensley JF, Sakr W, Yoo GH: Prognostic significance of p53 gene mutations in laryngeal cancer. Laryngoscope 1999;109:455-459
32. Narayana A, Vaughan AT, Gunaratne S, Kathuria S, Walter SA, Reddy SP: Is p53 an independent prognostic factor in patients with laryngeal carcinoma? Cancer 1998;82:286-291
33. Vielba R, Bilbao J, Ispizua A, Zabalza I, Alfaro J, Rezola R, Moreno E, Elorriaga J, Alonso I, Baroja A, de la Hoz C: p53 and cyclin D1 as prognostic factors in squamous cell carcinoma of the larynx. Laryngoscope 2003;113:167-172
34. McLaren R, Kuzu I, Dunnill M, Harris A, Lane D, Gatter KC: The relationship of p53 immunostaining to survival in carcinoma of the lung. Br J Cancer 1992;66:735-738
35. Passlick B, Izbicki JR, Riethmuller G, Pantel K: p53 in non-small-cell lung cancer. J Natl Cancer Inst 1994;86:801-803
36. Mashimo T, Watabe M, Hirota S, Hosobe S, Miura K, Tegtmeyer PJ, Rinker-Schaeffer CW, Watabe K: The expression of the KAI1 gene, a tumor metastasis suppressor, is directly activated by p53. Proc Natl Acad Sci U S A 1998;95:11307-11311
37. Briese J, Schulte HM, Sajin M, Bamberger C, Redlin K, Milde-Langosch K, Löning T, Bamberger A-M: Correlations between reduced expression of the metastasis suppressor gene KAI-1 and accumulation of p53 in uterine carcinomas and sarcomas. Virchows Arch 2008;453:89-96
38. Schindl M, Birner P, Bachtiary B, Breitenecker G, Selzer E, Oberhuber G: The impact of expression of the metastasis suppressor protein KAI1 on prognosis in invasive squamous cell cervical cancer. Anticancer Res 2000;20:4551-4555